Delivery Order SPE2DB22D1106-SPE2DB24FEUD0
- Not listed
- This federal contract award, valued at $5,494.68, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with an ultimate completion date of April 20, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $42,465.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a completion date of September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $18,505.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a prescription medication, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $27,796.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has a firm fixed-price pricing type with an ultimate completion date of November 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This federal contract award, valued at $17,361.85, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of January 17, 2025. The award is...
- This federal contract award, valued at $14,045.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a prescription medication, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award, valued at $22,860.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a prescription medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 7, 2025. It is not designated as a set-aside contract, indicating open competition....
- The U.S. Defense Logistics Agency (DLA) awarded a $77,306.44 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, to support military treatment facilities and federal healthcare programs. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December...
- This federal contract award, valued at $5,407.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET (4566325299) and has an ultimate completion date of November 5, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $108,347.29 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The award has a period of performance ending on September 30, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEUD0Delivery Order
This federal contract award, valued at $111,139.46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to support military healthcare programs. This is a Firm Fixed Price Delivery Order contract with a period of performance through May 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $111.1k | 5/29/24 |